BioPharmGuy News

July 27, 2023

With scientific discovery changing fast and our world changing faster, bold approaches in clinical trials are needed now more than

ever.

> Handle strategic, clinical, regulatory, and logistical complexities with ease

> Ensure you select the right regulatory pathway

> Benefit from bold thinking and decentralized solutions to put the patient experience first

Did you Know:

Veristat supported marketing applications for 8 therapies that received regulatory approval in 2022, mostly for therapies designed to treat rare diseases.

Explore our End-to-End Clinical Development, Registration, and Commercialization Solutions.

BioPharmGuy

We would like to bid all our European friends adieu for a while. Every one of you seems to have an out of office this time of year, so enjoy your forever vacation. I think last year I saw one that was scheduled to last four months. That’s not a vacation, that’s a sabbatical.

I think Facebook missed out when they launched Threads without having a desktop version. Casual users are fine with mobile-only, but professionals, such as journalists, are highly unlikely to post on their phone what they're seeing on their laptop. I follow many journalists and almost none post anything on Threads. Bummer.

-BPG

Double Vision

After adding a company out of Germany called AaviGen, we now list 27 companies whose names begin with repeating letters. 14 of those are double A’s.

If we exclude companies whose first two letters are both capitals (and thus likely to be some sort of acronym) we are left with 11 companies, only one which doesn’t start with A:

Aadi Bioscience

Aalto Scientific

aap Implantate

Aardvark Therapeutics

Aarti Pharmalabs

Aarvik Therapeutics

Aastrid Life Sciences

Aatru Medical

AaviGen

Aavis Pharmaceuticals

Llusern Scientific

With this knowledge, off you go into the world to face your greatest challenges.

Companies Added & Removed

25 companies added, 10 removed over the past two weeks.

Best New Name:

Doer Biologics

Worst New Name:

EG 427

You Will Be Missed:

Sequella

Summary of these updates can be downloaded as an Excel file from our downloads page.

Industry

Heads Roll at Biogen

After receiving full approval from the FDA for their early-stage Alzheimer's drug, Biogen promptly laid off 1000 people. The company gave a plethora of reasons as to why this was necessary, but it all comes down to the old “because we can”.

Emmaus Life Sciences

Big news here – the company’s sickle cell product, Endari has been approved for sale. In Oman.

The company estimates this approval will open up the possibility of up to 3000 new patients. Good news for those patients, but not so sure 3000 potential patients move the needle enough for a drug company to bother issuing a press release.

Earphones

Wavely is working on a smartphone-based ear infection diagnostic. Judging by the video it works by jamming the entire phone in your kid's ear. No problemo!

That thing is deeper in her ear than when grandma has you on speakerphone in public.

And who posts videos on Vimeo? Forgot that site existed.

Unpossible

You may want to sit down for this, but a team at Bentley University of Waltham, MA concluded that for-profit drug companies tend to maximize the financial gains from licensing their technologies more so than nonprofit Universities.

Astonishing.

Maybe next they'll shock us by showing Universities educate students more than drug companies educate employees.

Missed Her and Docked Her

Not sure if this is a British thing or what, but at ValiRx only the PhDs and men get a title on the Team page. The women without a PhD? They just get to be Stella and Zai.

Kincell Bio

Company got themselves a nice $36M fund raise this week. But they're a contract manufacturing company and that's a cutthroat business, so we decided to investigate how they could get such a huge round for a not-so-hugely-profitable sector.

According to Endpoints, this raise put their valuation at $66M. Quick math says they sold 54% of the company. Fifty-four! That's madness for a launch round. The founders are basically buying themselves jobs. Crazy. But perhaps even crazier is the investors who just threw $36M at an unproven service provider. #notmymoney

Health & Science

Health Problems

One way to solve the problem of expensive health care is to make it someone else's problem. Enterprising scammers are now using other peoples’ names and insurance information when they show up to the hospital.

If "it wasn't me" starts to become a legitimate reason to not pay your medical bill, that can mean only one thing: increased administrative bloat at hospitals and even higher prices.

Thanks, scammers!

End of Evolution

A group of scientists decided evolution can only go from water to land to water. At that point species cannot evolve to live on land again.

Never mind the fact that this is 100% untestable and thus more akin to religion than science, but to say anything is impossible when it comes to evolution is just dumb.

Bats are basically flying blind rats. There are fish with lights on them. There's a venomous mammal that lays eggs. But these scientists decided a dolphin can never evolve to crawl, no matter the environmental circumstances. Sure.

Wishcycling

Recycling is better than nothing, but using less stuff is still the best option. Unfortunately, lots of people don’t realize that and live with a clear conscience based on their decision to throw everything into the recycle bin.

You can't recycle plastic bags or paper towels curbside and you can’t put your recyclables into plastic bags - if you do, they go straight to the landfill.

Just because you put it in there doesn't mean it gets recycled.

Gators

We all know there are alligator populations in Florida and Louisiana. But did you know Arkansas has a couple thousand and Oklahoma has about a hundred?

Arkansas even went through a restocking back in the 70s & 80s. Hard to picture people back then being upset about a lack of alligators in their region.

Nowadays, a restocking program's demise would certainly be brought about by the NIMBYs: Not In My BaYou.

Promote Your Listing at BioPharmGuy

Check your website's analytics - BioPharmGuy is likely your top referrer.

Bump up those referrals even more with a Premium Listing. Learn more - Promoted Listings.

Subscribe!

If you're reading this and not a subscriber, please join our mailing list.